IRADIMED CORP - Common (IRMD)

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common
Shares outstanding
12,602,265
Total 13F shares
5,525,882
Share change
-100,897
Total reported value
$156,321,831
Price per share
$28.29
Number of holders
74
Value change
-$3,249,669
Number of buys
38
Number of sells
29

Institutional Holders of IRADIMED CORP - Common (IRMD) as of Q4 2022

As of 31 Dec 2022, IRADIMED CORP - Common (IRMD) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,525,882 shares. The largest 10 holders included Nine Ten Capital Management LLC, Soleus Capital Management, L.P., RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, RK Capital Management, LLC, Bares Capital Management, Inc., Russell Investments Group, Ltd., Ranger Investment Management, L.P., and ACADIAN ASSET MANAGEMENT LLC. This page lists 74 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.